Selection of β‐Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13‐Year Nationwide Population‐Based Study in Asia

BACKGROUND: It is not clear whether β(1)‐selective or nonselective β‐blockers should be used in patients with cirrhosis and acute myocardial infarction. METHODS AND RESULTS: Medical records were retrieved from Taiwan NHIRD (National Health Insurance Research Database) during 2001‐2013. Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Victor Chien‐Chia, Chen, Shao‐Wei, Ting, Pei‐Chi, Chang, Chih‐Hsiang, Wu, Michael, Lin, Ming‐Shyan, Hsieh, Ming‐Jer, Wang, Chao‐Yung, Chang, Shang‐Hung, Hung, Kuo‐Chun, Hsieh, I.‐Chang, Chu, Pao‐Hsien, Wu, Cheng‐Shyong, Lin, Yu‐Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404872/
https://www.ncbi.nlm.nih.gov/pubmed/30371327
http://dx.doi.org/10.1161/JAHA.118.008982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404872/
https://www.ncbi.nlm.nih.gov/pubmed/30371327
http://dx.doi.org/10.1161/JAHA.118.008982

Ejemplares similares